Maternal control of germline development
Maternal control of germline development
批准号:
10155083
负责人:
Jing Yang
金额:
$38.31万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2024-05-31
关键词:
AffectBindingCell ProliferationCellular biologyCodeCouplesDevelopmentDevelopmental BiologyEmbryoEnsureEnvironmentEventFertilizationGenetic TranscriptionGerm CellsGonadal structureHumanInfertilityKnowledgeLaboratory StudyLiteratureMessenger RNAModelingOocytesProliferatingRNARNA-Binding ProteinsReportingReproductive BiologyReproductive HealthResearchStructure of primordial sex cellSystemTimeTotipotencyTranslationsUbiquitinWorkXenopusegggonad developmentmulticatalytic endopeptidase complexnanonovelpreventrecruitsperm cellstem cell biology
中文摘要
摘要
原始生殖细胞(PGCs)是配子的前体细胞。有缺陷的PGC开发导致
生殖细胞减少或消除,最终导致人类不育,这影响了10-15%的人,
夫妻。在发育过程中,PGCs比性腺的形成早得多。PGCs必须
设法在无保护的躯体环境中生存很长时间,然后长时间迁移
找到性腺的距离在早期阶段,PGCs的特化及其增殖至关重要
以确保足够数量的PGCs能够到达性腺并分化成配子。大
大量文献表明,在迁移到性腺之前,PGC的发育严重依赖于
翻译和翻译后调节机制。了解PGC开发如何
因此,在翻译和翻译后水平上操作的基因与人类生殖高度相关。
健康我的实验室以非洲爪蟾为模型研究早期PGC的发展。我们最近报道
母亲死亡末端1(Dnd 1)对于卵母细胞中mRNA的不对称定位是重要的。后
在受精过程中,Dnd 1将翻译机器募集到nanos mRNA并促进nanos翻译。
通过这种机制,Dnd 1阻止PGCs的体细胞分化并保护其全能性。
我们最近的初步结果表明,Dnd 1在卵母细胞中被泛素-
独立的蛋白酶体系统。为了使Dnd 1积累并促进纳米翻译,
受精,编码蛋白酶体激活剂的RNA必须从dnd 1和其他种系中分离出来,
卵母细胞向胚胎过渡期间的特定母体因素。我们打算研究这部小说
mRNA易位事件为受精后PGC发育的启动做准备,并研究
如何从dnd 1和其他生殖系特异性母体中分离编码蛋白酶体激活剂的RNA
卵母细胞向胚胎过渡期间的因素。此外,我们有一个令人兴奋的发现,
PGC增殖波受母体Dzip 1的调节。我们将确定Dzip 1是否调节PGC
通过结合和修饰生殖系特异性RNA结合蛋白的活性来促进增殖。
此外,我们将确定合子转录网络的行为下游的Dzip 1,以控制
PGC增殖。这些工作将对我们理解基本细胞,
生殖和发育生物学。
英文摘要
Abstract
Primordial germ cells (PGCs) are the precursors of the gametes. Defective PGC development results in
reduction or elimination of germ cells and ultimately causes infertility in humans, which affects 10–15% of
couples. During development, PGCs are born much earlier than the formation of the gonads. PGCs must
manage to survive in the non-protective somatic environment for a long time and later migrate long
distances to find the gonads. Specification of PGCs and their proliferation during early stages are crucial
to ensure that sufficient number of PGCs can reach the gonads and differentiate into gametes. A large
body of literature has demonstrated that before migrating into the gonads, PGC development relies heavily
on translational and post-translational regulatory mechanisms. Understanding how PGC development is
operated at the translational and post-translation levels thus is highly relevant to human reproductive
health. My laboratory studies early PGC development using Xenopus as a model. We recently reported
that maternal Dead End1 (Dnd1) is important for asymmetric localization of mRNA in the oocyte. After
fertilization, Dnd1 recruits the translational machinery to nanos mRNA and promotes nanos translation.
Through this mechanism, Dnd1 prevents somatic differentiation of PGCs and protects their totipotency.
Our recent preliminary results reveal that Dnd1 is rapidly degraded in the oocyte by the ubiquitin-
independent proteasome system. In order for Dnd1 to accumulate and promote nanos translation after
fertilization, RNAs coding for proteasome activators must be separated from dnd1 and other germline
specific maternal factors during the oocyte-to-embryo transition. We propose to study how this novel
mRNA translocation event prepares for the initiation of PGC development after fertilization and investigate
how RNAs coding for proteasome activators are separated from dnd1 and other germline specific maternal
factors during the oocyte-to-embryo transition. Moreover, we have made an exciting finding that the first
wave of PGC proliferation is regulated by maternal Dzip1. We will determine if Dzip1 regulates PGC
proliferation via binding and modifying the activities of germline specific RNA-binding proteins.
Furthermore, we will identify the zygotic transcriptional network that acts downstream of Dzip1 to control
PGC proliferation. These works will make important contributions to our understanding of basic cell,
reproductive, and developmental biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis
-
批准号:10545992
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2022
-
负责人:Jing Yang
-
依托单位:
Functional interplay between Hippo and estrogen receptor ESR1
-
批准号:10573162
-
项目类别:
-
资助金额:$42.57万
-
财政年份:2022
-
负责人:Jing Yang
-
依托单位:
Apical-basal polarity in tumor progression and metastasis
-
批准号:10468642
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Apical-basal polarity in tumor progression and metastasis
-
批准号:10228549
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Maternal control of germline development
-
批准号:10410366
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
2019 International EMT Society meeting
-
批准号:9914655
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Apical-basal polarity in tumor progression and metastasis
-
批准号:10677660
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Maternal control of germline development
-
批准号:10625487
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Role of integrin VLA-6 in suppression of bone formation in myeloma
-
批准号:9206148
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2016
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10374409
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
-
批准号:9105357
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10557145
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10738319
-
项目类别:
-
资助金额:$8.58万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:9315114
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
-
批准号:8962918
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:8816864
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Dnd1 and repression of transcription in primordial germ cells
-
批准号:8888237
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10599661
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
-
批准号:10128071
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Dissecting molecular determinants of carcinoma dormancy in vivo
-
批准号:8976221
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2014
-
负责人:Jing Yang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: